Windtree’s $200M BNB Treasury Strategy Fails to Prevent Nasdaq Delisting

[TRADE_PLUGIN]BNBUSDT,BNBUSDT[/TRADE_PLUGIN] BNB News - Windtree Therapeutics faces delisting from Nasdaq on August 21 after failing to maintain the exchange's minimum $1 bid price requirement. The company's stock crashed nearly 80% following the announcement, closing at just $0.11 per share. This development represents a significant setback for Windtree, which had positioned itself as an innovator in corporate cryptocurrency adoption. In July, the company announced a strategic $200 million BNB treasury accumulation through a securities purchase agreement with blockchain investment firm Build and Build Corp. While this news initially drove a 20% pre-market surge, the crypto strategy ultimately proved insufficient to maintain Nasdaq compliance. Windtree now anticipates transitioning to over-the-counter trading under its current WINT symbol, though market success remains uncertain following this substantial setback.